Please confirm that you would like to log out of Medscape.
If you log out, you will be required to enter your username and password the next time you visit.
Log outCancel
Finally, a Big Win for a Monoclonal in Alzheimer'sMonoclonal antibodies may yet be an answer for treating Alzheimer's disease, results of an early but very encouraging study
have shown. Aducanumab lowered amyloid burden and slowed cognitive decline.
Medscape Medical News, Mar 23, 2015
Green Tea Linked to Lower Risk for Cognitive Decline Frequent consumption of green tea is associated with a dose-dependent lower risk for cognitive decline among Japanese elderly.
Black tea and coffee had no effect.
Medscape Medical News, Mar 25, 2015
New Drug Greatly Reduces Amyloid in CSF, PlasmaA once-daily, oral secretase inhibitor greatly reduces levels of amyloid in plasma and CSF with a prolonged effect, a study
shows. The compound works regardless of APOE epsilon 4 carrier status.